British Journal of Dermatology

Research Snippets
pp. i-i(1)

Pseudocatalase and narrowband ultraviolet B for vitiligo: clearing the picture
pp. 721-722(2)
Author: Gawkrodger, D.J.

Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid
pp. 723-731(9)
Authors: Gürcan, H.M.; Razzaque Ahmed, A.

Does chronic sunscreen use reduce vitamin D production to insufficient levels?
pp. 732-736(5)
Authors: Norval, M.; Wulf, H.C.

Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin
pp. 737-745(9)
Authors: Gazerani, P.; Pedersen, N.S.; Drewes, A.M.; Arendt-Nielsen, L.

Subclinical onychomycosis is associated with tinea pedis
pp. 746-749(4)
Author: Walling, H.W.

Psychological factors in leg ulceration: a case-control study
pp. 750-756(7)
Authors: Moffatt, C.J.; Franks, P.J.; Doherty, D.C.; Smithdale, R.; Steptoe, A.

Botulinum toxin abolishes sweating via impaired sweat gland responsiveness to exogenous acetylcholine
pp. 757-761(5)
Authors: Shibasaki, M.; Davis, S.L.; Cui, J.; Low, D.A.; Keller, D.M.; Crandall, C.G.

Antiplectin autoantibodies in subepidermal blistering diseases
pp. 762-771(10)
Authors: Buijsrogge, J.J.A.; de Jong, M.C.J.M.; Kloosterhuis, G.J.; Vermeer, M.H.; Koster, J.; Sonnenberg, A.; Jonkman, M.F.; Pas, H.H.

Staphylococcus aureus and hand eczema severity
pp. 772-777(6)
Authors: Haslund, P.; Bangsgaard, N.; Jarløv, J.O.; Skov, L.; Skov, R.; Agner, T.

Development and pilot-testing of a psoriasis screening tool
pp. 778-784(7)
Authors: Dominguez, P.L.; Assarpour, A.; Kuo, H.; Holt, E.W.; Tyler, S.; Qureshi, A.A.

Clonal T-cell populations are frequent in the skin and blood of patients with systemic sclerosis
pp. 785-790(6)
Authors: Kreuter, A.; Höxtermann, S.; Tigges, C.; Hahn, S.A.; Altmeyer, P.; Gambichler, T.

Evaluation of a polymerase chain reaction-restriction fragment length polymorphism assay for dermatophyte and nondermatophyte identification in onychomycosis
pp. 791-796(6)
Authors: Bontems, O.; Hauser, P.M.; Monod, M.

Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-γ release assay vs. tuberculin skin test
pp. 797-800(4)
Authors: Laffitte, E.; Janssens, J.P.; Roux-Lombard, P.; Thielen, A.M.; Barde, C.; Marazza, G.; Panizzon, R.G.; Saurat, J.-H.

Filaggrin mutations may confer susceptibility to chronic hand eczema characterized by combined allergic and irritant contact dermatitis
pp. 801-807(7)
Authors: Molin, S.; Vollmer, S.; Weiss, E.H.; Ruzicka, T.; Prinz, J.C.

Sites of dermatitis in a patch test population: hand dermatitis is associated with polysensitization
pp. 808-813(6)
Authors: Carlsen, B.C.; Andersen, K.E.; Menné, T.; Johansen, J.D.

Carbon dioxide laser treatment of rhinophyma: a review of 124 patients
pp. 814-818(5)
Authors: Madan, V.; Ferguson, J.E.; August, P.J.

Cellular and molecular features of lipoma tissue: comparison with normal adipose tissue
pp. 819-825(7)
Authors: Suga, H.; Eto, H.; Inoue, K.; Aoi, N.; Kato, H.; Araki, J.; Higashino, T.; Yoshimura, K.

Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients
pp. 826-830(5)
Authors: Nikolaou, V.A.; Papadavid, E.; Katsambas, A.; Stratigos, A.J.; Marinos, L.; Anagnostou, D.; Antoniou, C.

Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
pp. 831-839(9)
Authors: Sartorius, K.; Emtestam, L.; Jemec, G.B.E.; Lapins, J.

Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in the Netherlands
pp. 840-845(6)
Authors: van Hattem, S.; Aarts, M.J.; Louwman, W.J.; Neumann, H.A.M.; Coebergh, J.W.W.; Looman, C.W.N.; Nijsten, T.; de Vries, E.

How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two
pp. 846-853(8)
Authors: Flohr, C.; Weinmayr, G.; Weiland deceased, S.K.; Addo-Yobo, E.; Annesi-Maesano, I.; Björkstén, B.; Bråbäck, L.; Büchele, G.; Chico, M.; Cooper, P.; Clausen, M.; El Sharif, N.; Martinez Gimeno, A.; Mathur, R.S.; von Mutius, E.; Morales Suarez-Varela, M.; Pearce, N.; Svabe, V.; Wong, G.W.K.; Yu, M.; Zhong, N.S.; Williams, H.C.

Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study
pp. 854-860(7)
Authors: Huang, Y.L.; Chen, Y.J.; Lin, M.W.; Wu, C.Y.; Liu, P.C.; Chen, T.J.; Chen, Y.C.; Jih, J.S.; Chen, C.C.; Lee, D.D.; Chang, Y.T.; Wang, W.J.; Liu, H.N.

Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study
pp. 861-868(8)
Authors: Marazza, G.; Pham, H.C.; Schärer, L.; Pedrazzetti, P.P.; Hunziker, T.; Trüeb, R.M.; Hohl, D.; Itin, P.; Lautenschlager, S.; Naldi, L.; Borradori, L.

Quality of life in patients with epidermolysis bullosa
pp. 869-877(9)
Authors: Tabolli, S.; Sampogna, F.; Di Pietro, C.; Paradisi, A.; Uras, C.; Zotti, P.; Castiglia, D.; Zambruno, G.; Abeni, D.

Psychiatric comorbidity in adult eczema
pp. 878-883(6)
Authors: Schmitt, J.; Romanos, M.; Pfennig, A.; Leopold, K.; Meurer, M.

Filaggrin haploinsufficiency is highly penetrant and is associated with increased severity of eczema: further delineation of the skin phenotype in a prospective epidemiological study of 792 school children
pp. 884-889(6)
Authors: Brown, S.J.; Relton, C.L.; Liao, H.; Zhao, Y.; Sandilands, A.; McLean, W.H.I.; Cordell, H.J.; Reynolds, N.J.

Suberythemal ultraviolet B radiation alters the expression of cell cycle-related proteins in the epidermis of human subjects without leading to photoprotection
pp. 890-896(7)
Authors: Narbutt, J.; Norval, M.; Slowik-Rylska, M.; Jochymski, C.; Kozłowski, W.; Sysa-Jedrzejowska, A.; Rogowski-Tylman, M.; Lesiak, A.

Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial
pp. 897-903(7)
Authors: Gebauer, K.; Shumack, S.; Cowen, P.S.J.

Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study
pp. 904-909(6)
Authors: Saiag, P.; Bauhofer, A.; Bouscarat, F.; Aquilina, C.; Ortonne, J.P.; Dupin, N.; Mougin, C.

A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo
pp. 910-917(8)
Authors: Bakis-Petsoglou, S.; Le Guay, J.L.; Wittal, R.

Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin Chemoprevention Trial
pp. 918-924(7)
Authors: Geng, A.; Weinstock, M.A.; Hall, R.; Eilers, D.; Naylor, M.; Kalivas, J.

CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma
pp. 925-929(5)
Authors: Lennerz, J.K.M.; Perry, A.; Dehner, L.P.; Pfeifer, J.D.; Lind, A.C.

Detection of Merkel cell polyomavirus DNA in Merkel cell carcinomas
pp. 930-932(3)
Authors: Varga, E.; Kiss, M.; Szabó, K.; Kemény, L.

The `melanocyte-keratin' mystery revisited: neither normal human epidermal nor hair follicle melanocytes express keratin 16 or keratin 6 in situ
pp. 933-938(6)
Authors: Ramot, Y.; Gáspár, E.; Dendorfer, A.; Langbein, L.; Paus, R.

Chloracne in seven organic chemists exposed to novel polycyclic halogenated chemical compounds (triazoloquinoxalines)
pp. 939-943(5)
Authors: Gawkrodger, D.J.; Harris, G.; Bojar, R.A.

Identification of an oncostatin M receptor mutation associated with familial primary cutaneous amyloidosis
pp. 944-947(4)
Authors: Babilas, P.; Fiebig, B.S.; Aslanidis, C.; Hansen, J.; Röcken, C.; Schroeder, J.; Schmitz, G.; Weber, B.H.F.; Landthaler, M.; Vogt, T.

Experience with biologics for psoriasis in daily practice: switching is worth a try
pp. 948-951(4)
Authors: Lecluse, L.L.A.; deGroot, M.; Bos, J.D.; Spuls, P.I.

The familial feature of Tunisian endemic pemphigus foliaceus
pp. 951-953(3)
Authors: Abida, O.; Masmoudi, A.; Rebaï, A.; BenAyed, M.; Mahfoudh, N.; Kallel-Sellami, M.; Makni, S.; Joly, P.; Gilbert, D.; Makni, H.; Tron, F.; Masmoudi, H.; Turki, H.

Closure of dehisced operative sites without wound freshening results in acceptable rates of repeat dehiscence and infection
pp. 953-958(6)
Authors: Justiniano, H.; Eisen, D.B.

Altered p53 and Bcl-2 expression in keratinocytes of vulvar lichen sclerosus during pimecrolimus treatment
pp. 958-960(3)
Authors: Nissi, R.; Kotila, V.; Knuuti, E.; Väre, P.O.; Kauppila, S.

Onychofibroblasts induce hard keratin in skin keratinocytes in vitro
pp. 960-962(3)
Authors: Lee, D-Y.; Yang, J-M.; Mun, G-H.

An eclipse in the subungual space: a diagnostic sign for a subungual epidermal cyst?
pp. 962-963(2)
Authors: Takiyoshi, N.; Nakano, H.; Matsuzaki, Y.; Aizu, T.; Kaneko, T.; Rokunohe, D.; Akasaka, E.; Jin, K.; Sawamura, D.; Ohara, K.

Generalized pustular psoriasis induced by systemic glucocorticosteroids: four cases and recommendations for treatment
pp. 964-966(3)
Authors: Brenner, M.; Molin, S.; Ruebsam, K.; Weisenseel, P.; Ruzicka, T.; Prinz, J.C.

A homozygous mutation in the ferrochelatase gene underlies erythropoietic protoporphyria associated with palmar keratoderma - reply
pp. 966-967(2)
Authors: Holme, S.A.; Anstey, A.V.; Whatley, S.D.; Elder, G.H.; Badminton, M.N.

Successful treatment of Hailey-Hailey disease with topical 5-fluorouracil
pp. 967-968(2)
Authors: Dammak, A.; Camus, M.; Anyfantakis, V.; Guillet, G.

A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) manifesting adult-onset Still disease-like skin eruptions: report of a case and review of the Japanese patients
pp. 968-970(3)
Authors: Nakamura, M.; Kobayashi, M.; Tokura, Y.

News and Notices
pp. 970-970(1)